Mounjaro® (tirzepatide) Product Theater

Overview

Join a presentation by one of your peers to learn about Mounjaro. This program will include a review of efficacy and safety results from the SURPASS clinical trial program, including SURPASS-EARLY, as well as information on how to help your appropriate patients start and stay on Mounjaro. Attendees will have the opportunity to pose questions to the speaker at the end of the session.

Please see the Full Prescribing Information, including Boxed Warning, and Medication Guide provided at the product theater.

This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.